6/22/2022 4:23:50 PM
BD Announces Voluntary Recall On Intraosseous Products
6/13/2022 9:10:46 AM
BD Enters Into Partnership With Mayo Clinic Platform For Access To World's Largest Collection Of Clinical Data
6/8/2022 6:52:49 AM
CerTest Biotec And BD Announce Collaboration To Develop Molecular Diagnostic Test For Monkeypox Virus
6/6/2022 7:46:26 AM
BD To Acquire Parata Systems, Provider Of Pharmacy Automation Solutions, For $1.525 Bln
6/3/2022 6:52:25 AM
BD To Introduce New Cell Sorting Technology
5/12/2022 6:52:53 AM
BD Launches Fully Automated, High-Throughput Infectious Disease Molecular Diagnostic Platform In The U.S.
5/11/2022 6:52:26 AM
Babson, BD Expand Strategic Partnership
5/5/2022 6:35:00 AM
Becton, Dickinson and Company (BDX) Has Raised Its FY22 Revenue Estimate To $19.6 - $19.8 Bln From $19.55 - $19.75 Bln
5/5/2022 6:34:24 AM
Becton, Dickinson and Company (BDX) Has Raised Its FY22 EPS Estimate To 12.85 - 13.00 From 12.80 - 13.00
5/5/2022 6:31:38 AM
BD Q2 GAAP EPS $1.50; Adj EPS $3.18
4/26/2022 4:17:24 PM
Becton, Dickinson and Company (BDX) Declares Quarterly Dividend of $ 0.87, Record Date 6/9/2022
4/22/2022 6:51:22 AM
BD Announces Formation Of Sustainable Medical Technology Institute